{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:52:16Z","timestamp":1720799536847},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,8,1]]},"DOI":"10.1093\/ndt\/15.8.1228","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:37:35Z","timestamp":1027723055000},"page":"1228-1231","source":"Crossref","is-referenced-by-count":7,"title":["Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation"],"prefix":"10.1093","volume":"15","author":[{"given":"Rudolf P.","family":"W\u00fcthrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snjezana","family":"Cicvara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice M.","family":"Amb\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,8]]},"reference":[{"key":"key\n\t\t\t\t20180109102734_R1","doi-asserted-by":"crossref","unstructured":"Sollinger HW for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation1995; 60: 225\u2013232","DOI":"10.1097\/00007890-199508000-00003"},{"key":"key\n\t\t\t\t20180109102734_R2","doi-asserted-by":"crossref","unstructured":"European Mycophenolate Mofetil Cooperative Study Group. Placebo\u2010controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet1995; 345: 1321\u20131325","DOI":"10.1016\/S0140-6736(95)92534-1"},{"key":"key\n\t\t\t\t20180109102734_R3","doi-asserted-by":"crossref","unstructured":"The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation1996; 61: 1029\u20131037","DOI":"10.1097\/00007890-199604150-00008"},{"key":"key\n\t\t\t\t20180109102734_R4","doi-asserted-by":"crossref","unstructured":"Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C, for the International Mycophenolate Mofetil Renal Transplant Study Groups. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double\u2010blind, clinical studies in prevention of rejection. Transplantation1997; 63: 39\u201347","DOI":"10.1097\/00007890-199701150-00008"},{"key":"key\n\t\t\t\t20180109102734_R5","doi-asserted-by":"crossref","unstructured":"Wiesel M, Carl S for the European Mycophenolate Mofetil Cooperative Study Group. A placebo controlled study of mycophenolate mofetil used in combination with cyclosporine and corticosteroids for the prevention of acute rejection in renal allograft recipients: 1\u2010year results. J Urol1998; 159: 28\u201333","DOI":"10.1016\/S0022-5347(01)64000-X"},{"key":"key\n\t\t\t\t20180109102734_R6","doi-asserted-by":"crossref","unstructured":"Kim YS, Moon JI, Kim SI, Park K. Clear benefit of mycophenolate mofetil\u2010based triple therapy in reducing the incidence of acute rejection after living donor renal transplantations. Transplantation1999; 68: 578\u2013581","DOI":"10.1097\/00007890-199908270-00023"},{"key":"key\n\t\t\t\t20180109102734_R7","doi-asserted-by":"crossref","unstructured":"W\u00fcthrich RP, Weinreich T, Amb\u00fchl PM, Schwarzkopf AK, Candinas D, Binswanger U. Reduced kidney transplant rejection rate and pharmaco\u2010economic advantage of mycophenolate mofetil. Nephrol Dial Transplant1999; 14: 394\u2013399","DOI":"10.1093\/ndt\/14.2.394"},{"key":"key\n\t\t\t\t20180109102734_R8","doi-asserted-by":"crossref","unstructured":"European Mycophenolate Mofetil Cooperative Study Group. Mycophenolate mofetil in renal transplantation: 3\u2010year results from the placebo\u2010controlled trial. Transplantation1999; 68: 391\u2013396","DOI":"10.1097\/00007890-199908150-00011"},{"key":"key\n\t\t\t\t20180109102734_R9","doi-asserted-by":"crossref","unstructured":"US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil in cadaveric renal transplantation. Am J Kidney Dis1999; 34: 296\u2013303","DOI":"10.1016\/S0272-6386(99)70358-6"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/15\/8\/1228\/23367990\/151228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T09:21:00Z","timestamp":1515576060000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/15\/8\/1228\/1808791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,1]]},"references-count":9,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2000,8]]},"published-print":{"date-parts":[[2000,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/15.8.1228","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,8]]},"published":{"date-parts":[[2000,8,1]]}}}